1001

A MINORITY WITH CHILDHOOD DISORDERS OF GUT-BRAIN INTERACTIONS CONTINUE IN ADULTHOOD, BUT MOOD DISORDERS INCREASE THE ODDS OF CHILDHOOD GASTROINTESTINAL SYMPTOMS PERSISTING INTO ADULTHOOD

Date
May 21, 2024

Introduction
Disorders of Gut-Brain Interaction (DGBI) are chronic, remitting and relapsing conditions which may originate in childhood. Irritable bowel syndrome (IBS) and functional dyspepsia (FD) are two most common DGBIs seen in clinical practice. However many childhood illnesses are minor self-limiting viral or bacterial diseases with no known long-term consequences. There is currently a poor understanding of whether DGBI diagnosed in childhood has direct consequences for the same condition persisting or recurring in adulthood, or what might be risk or risk-protective factors for such persistence. Further, there are no data on this question from general practice, where the majority of DGBIs are diagnosed and managed. This study aimed to document the proportion of childhood-diagnosed IBS and FD that was further identified in patients’ general practice medical record in adulthood and what factors were associated with recurrence.
Methods
General practice records were obtained for over 1.2 million patients in the United Kingdom, of whom over 60,000 spanned both childhood and adulthood years. Patients with diagnosed organic gastrointestinal disorder were excluded. Other gastrointestinal and psychological conditions diagnosed in childhood, prior to DGBI diagnosis, or at any time, along with available sociodemographic factors were used to identify factors associated with repeat diagnosis in adulthood.
Results
Overall, 11% of IBS and 20% of FD patients diagnosed in childhood were found to have repeat diagnoses of the same condition in adulthood. Female sex (OR=2.02) was associated with increased risk of repeat diagnosis for IBS but socioeconomic status and ethnicity were not risk factors for either DGBI studied. Childhood diagnosis of gastritis (OR=0.46) was a protective factor for IBS while childhood prescription of NSAIDs (OR=1.31, 95% CI 1.09, 1.56) was a risk factor. For FD, a childhood diagnosis of asthma (OR=1.30, 95% CI 1.00, 1.70) was a risk factor for a repeat diagnosis in adulthood. Anxiety was associated with increased risk of both IBS (OR=1.24, 95% CI 1.00, 1.54) and FD (OR=1.48 95% CI 1.11, 1.97) as was depression for both IBS (OR=1.34, 95% CI 1.11, 1.62) and FD (OR=1.88 95% CI 1.47, 2.42).
Conclusions
Childhood diagnoses of DGBI are associated with the same disorder as adults in a small but significant percentage of patients. This underscores the importance of effective management of childhood cases of DGBI and that monitoring should continue into adulthood. Risk factor analysis suggests that female patients should receive particular attention, anxiety and depression should be effectively treated and the prescription of NSAIDs to children should be done judiciously.

Tracks

Related Products

Thumbnail for SMALL INTESTINAL BACTERIAL OVERGROWTH AS ASSESSED BY BREATH TESTING: A PROSPECTIVE EVALUATION TO THE GOLD STANDARD ASPIRATE
SMALL INTESTINAL BACTERIAL OVERGROWTH AS ASSESSED BY BREATH TESTING: A PROSPECTIVE EVALUATION TO THE GOLD STANDARD ASPIRATE
BACKGROUND: Small intestinal bacterial overgrowth (SIBO) is defined as the presence of excessive and abnormal types of bacteria in the small intestine. SIBO has been linked to several gastrointestinal and extraintestinal diseases…
Thumbnail for ANTIBIOTICS, URBAN ENVIRONMENT AND WESTERN DIET PATTERN INCREASE RISK OF PAEDIATRIC INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
ANTIBIOTICS, URBAN ENVIRONMENT AND WESTERN DIET PATTERN INCREASE RISK OF PAEDIATRIC INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
BACKGROUND: Our team (Xiong et al. 2021) recently developed an infliximab population pharmacokinetic (popPK) model in children and young adults with Crohn’s disease (CD). We found that prediction accuracy improved when all five covariates of drug clearance were included…
Thumbnail for BEYOND CALORIES FOR DIETARY MANAGEMENT IN MAFLD: EMERGING EVIDENCE FOR DIET MODULATION VIA THE GUT-LIVER-AXIS
BEYOND CALORIES FOR DIETARY MANAGEMENT IN MAFLD: EMERGING EVIDENCE FOR DIET MODULATION VIA THE GUT-LIVER-AXIS
BACKGROUND: Despite rapidly increasing global burden of metabolic-associated fatty liver disease (MAFLD), therapeutic options remain limited. Dietary modulation is a key component of MAFLD management, with reduced energy intake for weight loss considered first line therapy…
Thumbnail for VARIATIONS OF THE MUCOSA ASSOCIATED MICROBIOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, ULCERATIVE COLITIS AND ASYMPTOMATIC CONTROLS ALONG THE GASTROINTESTINAL TRACT
VARIATIONS OF THE MUCOSA ASSOCIATED MICROBIOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, ULCERATIVE COLITIS AND ASYMPTOMATIC CONTROLS ALONG THE GASTROINTESTINAL TRACT
This session will cover the pathogenic and non-pathogenic constituents of the gut microbiome that induce local and systemic inflammatory response and play an important role in disease development…